Rice Jerry M
Department of Oncology, Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, PO Box 571465, 3800 Reservoir Road, NW Washington, DC 20057-1465, USA.
Mutat Res. 2005 Feb 7;580(1-2):3-20. doi: 10.1016/j.mrgentox.2004.09.008.
Acrylamide is carcinogenic to experimental mice and rats, causing tumors at multiple organ sites in both species when given in drinking water or by other means. In mice, acrylamide increases the incidence of alveologenic lung tumors and initiates skin tumors after dermal exposures. In two bioassays in rats, acrylamide administered in drinking water consistently induced peritesticular mesotheliomas, thyroid follicular cell tumors, and mammary gland tumors, as well as primary brain tumors when all such tumors were included in data analysis. In one of the rat bioassays, increased numbers of adrenal pheochromocytomas, adenomas of pituitary and clitoral glands, papillomas of the oral cavity, and adenocarcinomas of the uterus also occurred. In both humans and experimental animals, a significant fraction of ingested acrylamide is converted metabolically to the chemically reactive and genotoxic epoxide, glycidamide, which is likely to play an important role in the carcinogenicity of acrylamide. No studies on the carcinogenicity of glycidamide have been published, but bioassays of this compound are in progress. Epidemiologic studies of possible health effects from exposures to acrylamide have not produced consistent evidence of increased cancer risk, in either occupationally exposed workers or the general populations of several countries in which acrylamide is present in certain foods and beverages. A doubling of risk for pancreatic cancer was observed in the most highly exposed workers within the largest industrial cohort, but no consistent exposure-response relationships were identified. Retrospective re-analyses of previously conducted case-control studies of cancer incidence in several European populations have identified no causal relationship between consumption of foods or beverages that contain acrylamide and the incidence of cancers at various sites including kidney, large bowel, urinary bladder, oral cavity, pharynx, larynx, esophagus, breast, and ovary. These retrospective studies of cancer incidence in relation to acrylamide in food have limited power to detect increased cancer risks, and have been criticized on various grounds, but they do indicate that no major cancer risks are attributable to intake of acrylamide in Western diets.
丙烯酰胺对实验小鼠和大鼠具有致癌性,通过饮水或其他方式给予时,会在这两个物种的多个器官部位引发肿瘤。在小鼠中,丙烯酰胺会增加肺泡源性肺肿瘤的发生率,并在皮肤接触后引发皮肤肿瘤。在两项大鼠生物测定中,当所有此类肿瘤都纳入数据分析时,饮水中给予丙烯酰胺会持续诱发睾丸周围间皮瘤、甲状腺滤泡细胞肿瘤和乳腺肿瘤以及原发性脑肿瘤。在其中一项大鼠生物测定中,肾上腺嗜铬细胞瘤、垂体和阴蒂腺瘤、口腔乳头状瘤以及子宫腺癌的数量也有所增加。在人类和实验动物中,摄入的丙烯酰胺有很大一部分会通过代谢转化为具有化学反应性和遗传毒性的环氧化物——缩水甘油酰胺,这可能在丙烯酰胺的致癌性中起重要作用。关于缩水甘油酰胺致癌性的研究尚未发表,但该化合物的生物测定正在进行中。对接触丙烯酰胺可能产生的健康影响进行的流行病学研究,在职业暴露工人或几个国家的普通人群中,均未得出癌症风险增加的一致证据,这些国家的某些食品和饮料中存在丙烯酰胺。在最大的工业队列中,暴露程度最高的工人中观察到胰腺癌风险增加了一倍,但未发现一致的暴露 - 反应关系。对欧洲几个群体先前进行的癌症发病率病例对照研究的回顾性重新分析表明,食用含有丙烯酰胺的食品或饮料与包括肾脏、大肠、膀胱、口腔、咽、喉、食管、乳腺和卵巢在内的各个部位的癌症发病率之间没有因果关系。这些关于食物中丙烯酰胺与癌症发病率关系的回顾性研究检测癌症风险增加的能力有限,并受到了各种批评,但它们确实表明,西方饮食中摄入丙烯酰胺不会导致重大癌症风险。